Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 18.75 GBX Market Closed
Market Cap: 77.3m GBX
Have any thoughts about
Creo Medical Group PLC?
Write Note

Creo Medical Group PLC
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Creo Medical Group PLC
Cash Equivalents Peer Comparison

Comparables:
SN
LIVN
EKF
AGL
B
BELL

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Creo Medical Group PLC
LSE:CREO
Cash Equivalents
ÂŁ9.8m
CAGR 3-Years
-32%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Cash Equivalents
$346.4m
CAGR 3-Years
24%
CAGR 5-Years
36%
CAGR 10-Years
11%
EKF Diagnostics Holdings PLC
LSE:EKF
Cash Equivalents
ÂŁ9.8m
CAGR 3-Years
-22%
CAGR 5-Years
-5%
CAGR 10-Years
-1%
Angle PLC
LSE:AGL
Cash Equivalents
ÂŁ17.9m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Belluscura PLC
LSE:BELL
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Creo Medical Group PLC's Cash Equivalents?
Cash Equivalents
9.8m GBP

Based on the financial report for Jun 30, 2024, Creo Medical Group PLC's Cash Equivalents amounts to 9.8m GBP.

What is Creo Medical Group PLC's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-24%

Over the last year, the Cash Equivalents growth was -15%. The average annual Cash Equivalents growth rates for Creo Medical Group PLC have been -32% over the past three years , -24% over the past five years .

Back to Top